Upper Gastrointestinal Cancers

Access ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.

Thierry Conroy reporting from ASCO 2018 describes the design and key results of the trial that compared adjuvant modified (m) FOLFIRINOX regimen with standard gemcitabine in patients with resected pancreatic cancer.

Clinical Practice Guidelines

Factsheets on Biomarkers

03 Aug 2015 HER2 in Gastric Cancer Giuseppe Viale